Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 20, 2025 • 4:30 AM ET

Date/Time Source News Release
04/17/2025 06:00 AM EDT ACCESS Newswire MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
04/01/2025 10:00 PM EDT ACCESS Newswire MedMira Reports Second Quarter Results FY2025
02/27/2025 04:30 PM EST ACCESS Newswire MedMira Announces Partnership with MediGroup Physician Services in the United States
02/25/2025 06:00 PM EST ACCESS Newswire MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
01/21/2025 06:00 PM EST ACCESS Newswire MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
01/14/2025 05:00 PM EST ACCESSWIRE MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
01/09/2025 06:00 PM EST ACCESSWIRE MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
12/30/2024 10:00 PM EST ACCESSWIRE MedMira Reports First Quarter Results FY2025
12/24/2024 04:55 PM EST Canada Newswire TSX Venture Exchange Stock Maintenance Bulletins
12/24/2024 12:16 PM EST Canada Newswire Canadian Investment Regulatory Organization Trade Resumption - MIR
Page

Additional News

As of June 20, 2025 • 4:30 AM ET

Date/Time Source News Release
10/03/2022 07:04 AM EDT News Direct MedMira provides Progress Update
01/18/2021 05:30 PM EST Investing News Network Top Canadian Biotech Stocks of 2020
01/13/2021 08:57 AM EST FinancialBuzz.com Why There's Still Need for Rapid Accessible Pathogen Testing, During and After the Crisis
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.